Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds.

Journal article

Cruz-Migoni A. et al, (2019), Proceedings of the National Academy of Sciences of the United States of America, 116, 2545 - 2550

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family

Journal article

Bataille CJR. et al, (2017), Bioorganic & Medicinal Chemistry, 25, 2657 - 2665